Deep Health AI appoints Bhupesh Swami as independent director

0 min read     Updated on 02 Jul 2026, 06:46 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Deep Health AI India Ltd appointed Bhupesh Swami as an Additional Non-Executive Independent Director for a two-year term from July 02, 2026, to July 01, 2028. The board approved the appointment via circular resolution. Swami holds an MIB in Export-Import from CMS, Udaipur, and has no familial relationships with other directors.

powered bylight_fuzz_icon
44543794

*this image is generated using AI for illustrative purposes only.

deep health ai has appointed Bhupesh Swami as an Additional Non-Executive Independent Director on its board, effective July 02, 2026. The appointment was approved by the Board of Directors through a circular resolution on the same day. Swami will serve a two-year term, ending on July 01, 2028.

The disclosure was made to BSE Limited in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Swami is not related to any other directors on the board.

Swami holds a Master India Boards (MIB) specialization in Export-Import, which he completed in 2016 from CMS, Udaipur. The appointment is part of the company's board governance structure.

Appointment Details

Particular Description
Name of Director Mr. Bhupesh Swami
DIN 07999261
Designation Additional Non-Executive Independent Director
Date of Appointment July 02, 2026
Term of Appointment Two years (July 02, 2026 to July 01, 2028)

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%-1.82%-2.26%-64.99%-48.20%+107.69%

How will Bhupesh Swami's expertise in export-import influence Deep Health AI's strategic direction?

What specific governance improvements does the company expect from this board expansion?

Will Deep Health AI announce further board appointments to strengthen its leadership team?

Deep Health AI acquires 6.37% stake in Leapfrog Engineering

1 min read     Updated on 25 Jun 2026, 11:23 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Deep Health AI India Ltd acquired a 6.37% stake in Leapfrog Engineering Services Ltd for ₹19.92 crore on June 24, 2026. The purchase of 9,030,000 equity shares at ₹22.06 each was made for routine investment purposes. Leapfrog Engineering Services specializes in EPCC services for industries like oil and gas and pharma.

powered bylight_fuzz_icon
43955592

*this image is generated using AI for illustrative purposes only.

Deep Health AI India Ltd has acquired a 6.37% stake in Leapfrog Engineering Services Ltd for a total consideration of ₹19.92 crore. The acquisition was completed on June 24, 2026, through the purchase of 9,030,000 equity shares at a price of ₹22.06 each, including a premium of ₹21.06 per share. The transaction was disclosed to BSE Limited on June 25, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The acquisition does not constitute a related party transaction, and the promoter or promoter group of Deep Health AI India Ltd holds no interest in the target entity. The company stated that the investment was made for routine investment purposes. No governmental or regulatory approvals were required for the completion of this transaction.

Leapfrog Engineering Services Ltd operates in the industrials, engineering, and construction sector. The company specializes in engineering, procurement, construction, and commissioning (EPCC) services, with a focus on electrical, instrumentation, fire safety, modular substation, and automation systems. Its client base spans industries such as oil and gas, food processing, pharma, and metals.

Financials of Leapfrog Engineering Services Ltd

The target entity reported a turnover of ₹13,466.24 lakh for the financial year ended March 31, 2025. Leapfrog Engineering Services Ltd was incorporated on May 9, 2005, and maintains its presence in India.

Financial Year Turnover (in ₹)
FY 2022-2023 10,417.86 Lakhs
FY 2023-2024 15,785.42 Lakhs
FY 2024-2025 13,466.24 Lakhs

Transaction Details

The acquisition exceeded the materiality threshold of Deep Health AI India Ltd, triggering the mandatory disclosure. The shares were acquired via cash consideration. The target company has over 20 years of experience in the sector, with capabilities in executing large-scale projects including refineries, petrochemical plants, and facilities for metals and chemicals.

Historical Stock Returns for Deep Health AI

1 Day5 Days1 Month6 Months1 Year5 Years
-0.92%-1.82%-2.26%-64.99%-48.20%+107.69%

Will Deep Health AI India Ltd increase its stake in Leapfrog Engineering Services Ltd beyond the current 6.37% in the future?

How will this strategic investment influence Deep Health AI India Ltd's diversification into the industrials and engineering sectors?

What are the expected synergies between Deep Health AI India Ltd and Leapfrog Engineering Services Ltd given their different industry focuses?

More News on Deep Health AI

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-48.20%